ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 72 filers reported holding ADAMAS PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.85 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,186,000 | +1.4% | 35,000 | -49.4% | 0.67% | -2.0% |
| Q4 2016 | $1,170,000 | +7.8% | 69,215 | +4.7% | 0.68% | -8.7% |
| Q3 2016 | $1,085,000 | +26.9% | 66,110 | +17.0% | 0.75% | +71.2% |
| Q2 2016 | $855,000 | +195.8% | 56,500 | +182.5% | 0.44% | +312.3% |
| Q1 2016 | $289,000 | -91.3% | 20,000 | -82.9% | 0.11% | -92.8% |
| Q4 2015 | $3,321,000 | +94.9% | 117,257 | +15.2% | 1.47% | +25.9% |
| Q3 2015 | $1,704,000 | – | 101,766 | – | 1.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,423,578 | $8,826,000 | 6.08% |
| Healthcare Value Capital, LLC | 200,000 | $1,240,000 | 2.33% |
| ARMISTICE CAPITAL, LLC | 2,700,000 | $16,740,000 | 1.06% |
| DELTEC ASSET MANAGEMENT LLC | 550,836 | $3,415,000 | 0.75% |
| Broadfin Capital, LLC | 441,088 | $2,735,000 | 0.60% |
| Kerrisdale Advisers, LLC | 229,347 | $1,422,000 | 0.51% |
| Worth Venture Partners, LLC | 87,908 | $545,000 | 0.30% |
| Mosaic Family Wealth, LLC | 91,314 | $566,000 | 0.24% |
| EMERALD ADVISERS, LLC | 700,176 | $4,341,000 | 0.17% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 616,664 | $3,823,000 | 0.15% |